Literature DB >> 28588356

Molecular Pathogenesis of Alzheimer's Disease: An Update.

Alfredo Sanabria-Castro1, Ileana Alvarado-Echeverría1, Cecilia Monge-Bonilla1.   

Abstract

Dementia is a chronic or progressive syndrome, characterized by impaired cognitive capacity beyond what could be considered a consequence of normal aging. It affects the memory, thinking process, orientation, comprehension, calculation, learning ability, language, and judgment; although awareness is usually unaffected. Alzheimer's disease (AD) is the most common form of dementia; symptoms include memory loss, difficulty solving problems, disorientation in time and space, among others. The disease was first described in 1906 at a conference in Tubingen, Germany by Alois Alzheimer. One hundred and ten years since its first documentation, many aspects of the pathophysiology of AD have been discovered and understood, however gaps of knowledge continue to exist. This literature review summarizes the main underlying neurobiological mechanisms in AD, including the theory with emphasis on amyloid peptide, cholinergic hypothesis, glutamatergic neurotransmission, the role of tau protein, and the involvement of oxidative stress and calcium.

Entities:  

Keywords:  Alzheimer's disease; Amyloid; Dementia; Neurobiology; Pathogenesis; Review

Year:  2017        PMID: 28588356      PMCID: PMC5448443          DOI: 10.1159/000464422

Source DB:  PubMed          Journal:  Ann Neurosci        ISSN: 0972-7531


  100 in total

Review 1.  Alzheimer's disease: strategies for disease modification.

Authors:  Martin Citron
Journal:  Nat Rev Drug Discov       Date:  2010-05       Impact factor: 84.694

2.  Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction.

Authors:  Nicola Origlia; Massimo Righi; Simona Capsoni; Antonino Cattaneo; Fang Fang; David M Stern; John Xi Chen; Ann Marie Schmidt; Ottavio Arancio; Shi Du Yan; Luciano Domenici
Journal:  J Neurosci       Date:  2008-03-26       Impact factor: 6.167

Review 3.  Cyclophilin D in mitochondrial pathophysiology.

Authors:  Valentina Giorgio; Maria Eugenia Soriano; Emy Basso; Elena Bisetto; Giovanna Lippe; Michael A Forte; Paolo Bernardi
Journal:  Biochim Biophys Acta       Date:  2009-12-21

4.  Differential regulation of BACE1 promoter activity by nuclear factor-kappaB in neurons and glia upon exposure to beta-amyloid peptides.

Authors:  Krystyn Z Bourne; Diana C Ferrari; Christine Lange-Dohna; Steffen Rossner; Thomas G Wood; J Regino Perez-Polo
Journal:  J Neurosci Res       Date:  2007-05-01       Impact factor: 4.164

5.  Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation.

Authors:  Xian Zhang; Kun Zhou; Ruishan Wang; Jiankun Cui; Stuart A Lipton; Francesca-Fang Liao; Huaxi Xu; Yun-wu Zhang
Journal:  J Biol Chem       Date:  2007-02-15       Impact factor: 5.157

Review 6.  Autophagy, amyloidogenesis and Alzheimer disease.

Authors:  Ralph A Nixon
Journal:  J Cell Sci       Date:  2007-12-01       Impact factor: 5.285

Review 7.  Amyloid beta peptides and glutamatergic synaptic dysregulation.

Authors:  Kodeeswaran Parameshwaran; Muralikrishnan Dhanasekaran; Vishnu Suppiramaniam
Journal:  Exp Neurol       Date:  2007-10-24       Impact factor: 5.330

Review 8.  A century of Alzheimer's disease.

Authors:  Michel Goedert; Maria Grazia Spillantini
Journal:  Science       Date:  2006-11-03       Impact factor: 47.728

Review 9.  Models of β-amyloid induced Tau-pathology: the long and "folded" road to understand the mechanism.

Authors:  Ilie-Cosmin Stancu; Bruno Vasconcelos; Dick Terwel; Ilse Dewachter
Journal:  Mol Neurodegener       Date:  2014-11-18       Impact factor: 14.195

10.  Bacopaside I ameliorates cognitive impairment in APP/PS1 mice via immune-mediated clearance of β-amyloid.

Authors:  Yuanyuan Li; Xing Yuan; Yunheng Shen; Jing Zhao; Rongcai Yue; Fang Liu; Weiwei He; Rui Wang; Lei Shan; Weidong Zhang
Journal:  Aging (Albany NY)       Date:  2016-03       Impact factor: 5.682

View more
  82 in total

1.  Formaldehyde, Epigenetics, and Alzheimer's Disease.

Authors:  Fei Wang; Danqi Chen; Peipei Wu; Catherine Klein; Chunyuan Jin
Journal:  Chem Res Toxicol       Date:  2019-04-19       Impact factor: 3.739

2.  Ameliorative effects of astaxanthin on brain tissues of alzheimer's disease-like model: cross talk between neuronal-specific microRNA-124 and related pathways.

Authors:  Hala A Hafez; Maher A Kamel; Mohamed Y Osman; Hassan My Osman; Samar S Elblehi; Shimaa A Mahmoud
Journal:  Mol Cell Biochem       Date:  2021-02-11       Impact factor: 3.396

Review 3.  An Update on Dual Orexin Receptor Antagonists and Their Potential Role in Insomnia Therapeutics.

Authors:  Kayla Janto; J Roxanne Prichard; Snigdha Pusalavidyasagar
Journal:  J Clin Sleep Med       Date:  2018-08-15       Impact factor: 4.062

Review 4.  Potential Role of Extracellular CIRP in Alcohol-Induced Alzheimer's Disease.

Authors:  Archna Sharma; Max Brenner; Ping Wang
Journal:  Mol Neurobiol       Date:  2020-08-21       Impact factor: 5.590

5.  Sulfhydration of AKT triggers Tau-phosphorylation by activating glycogen synthase kinase 3β in Alzheimer's disease.

Authors:  Tanusree Sen; Pampa Saha; Tong Jiang; Nilkantha Sen
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-12       Impact factor: 11.205

Review 6.  The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases.

Authors:  Filippo Baldacci; Sonia Mazzucchi; Alessandra Della Vecchia; Linda Giampietri; Nicola Giannini; Maya Koronyo-Hamaoui; Roberto Ceravolo; Gabriele Siciliano; Ubaldo Bonuccelli; Fanny M Elahi; Andrea Vergallo; Simone Lista; Filippo Sean Giorgi; Harald Hampel
Journal:  Expert Rev Mol Diagn       Date:  2020-02-27       Impact factor: 5.225

Review 7.  Sphingolipids in neurodegeneration (with focus on ceramide and S1P).

Authors:  Guanghu Wang; Erhard Bieberich
Journal:  Adv Biol Regul       Date:  2018-09-22

8.  Nanopore Fabrication and Application as Biosensors in Neurodegenerative Diseases.

Authors:  Brian Lenhart; Xiaojun Wei; Zehui Zhang; Xiaoqin Wang; Qian Wang; Chang Liu
Journal:  Crit Rev Biomed Eng       Date:  2020

Review 9.  Cholinesterase targeting by polyphenols: A therapeutic approach for the treatment of Alzheimer's disease.

Authors:  Nasimudeen R Jabir; Fayaz Rahman Khan; Shams Tabrez
Journal:  CNS Neurosci Ther       Date:  2018-05-16       Impact factor: 5.243

Review 10.  18F-labeled radiopharmaceuticals for the molecular neuroimaging of amyloid plaques in Alzheimer's disease.

Authors:  Luca Filippi; Agostino Chiaravalloti; Oreste Bagni; Orazio Schillaci
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.